SynthesisFrontiers in immunology2025

The efficacy and safety of regorafenib/fruquintinib combined with PD-1/PD-L1 for metastatic colorectal cancer: a meta-analysis based on single-arm studies.

Fan Yang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.